CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT05727683 · UNKNOWN
Trial details
- NCT number
- NCT05727683
- Sponsor
- Shanghai Ming Ju Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2023-10-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.